Medicine for psoriasis

As per available reports about 21 journals, 09 Conferences, 11 workshops are presently dedicated exclusively to medicine for psoriasis and about 591 articles are being published on the current trends in medicine for psoriasis. In terms of research annually, USA, India, Japan, Brazil and Canada are some of the leading countries where maximum studies related to medicine for psoriasis are being carried out. Psoriasis is a chronic inflammatory skin disease. It is a complex, reoccurring autoimmune disorder characterized by red, flaky patches on the skin. The primary goal of treatment is to stop the skin cells from growing so quickly. No cure for psoriasis exists, but a number of good treatment options are available to control the problem. Since this disease is incurable, psoriasis control must be considered for the long term. The spectrum of treatment options depends on the extent and severity as well as the emotional response to the disease: topical agents, phototherapy, and systemic agents. All of these treatments may be used alone or in combination with one another.

The Journal of Clinical & Experimental Dermatology Research is an academic journal – hosted by OMICS International – a pioneer in open access publishing–and is listed among the top 10 journals in medicine for psoriasis. Each year research scientists have noticed a rise in the number of congresses being held in this field. The Journal of Clinical & Experimental Dermatology Research provides a unique platform to researchers and scientist to explore the advanced and latest research developments in the field of medicine for psoriasis thus bridging the gap between researchers and young scientists.

OMICS Group organizing 5th International Conference on Clinical & Experimental Dermatology with the theme “Blooming landscapes in cardio research” with a well reputed organizing committee during July 13-15, 2015 New Orleans, USA.